295 related articles for article (PubMed ID: 16611543)
1. [Erysipelas].
Caetano M; Amorin I
Acta Med Port; 2005; 18(5):385-93. PubMed ID: 16611543
[TBL] [Abstract][Full Text] [Related]
2. [Non-Necrotizing Acute Dermo-Hypodermal Infections: Erysipela and Infectious Cellulitis].
Rodrigues MA; Caetano M; Amorim I; Selores M
Acta Med Port; 2021 Mar; 34(3):217-228. PubMed ID: 33971117
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic criteria for erysipelas].
Vaillant L
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):326-33. PubMed ID: 11319359
[TBL] [Abstract][Full Text] [Related]
4. [Management of erysipelas].
Granier F
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):429-42. PubMed ID: 11319375
[TBL] [Abstract][Full Text] [Related]
5. [Erysipelas and necrotizing fasciitis: management (short text). Consensus conference. French Society of Dermatology].
Ann Med Interne (Paris); 2000 Oct; 151(6):465-70. PubMed ID: 11104925
[No Abstract] [Full Text] [Related]
6. [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Boukari T; Pitché P; Tchangaï-Walla K
Med Trop (Mars); 2011 Apr; 71(2):162-4. PubMed ID: 21695874
[TBL] [Abstract][Full Text] [Related]
7. [Cellulitis: clinical manifestations and management].
Blum CL; Menzinger S; Genné D
Rev Med Suisse; 2013 Oct; 9(401):1812-5. PubMed ID: 24191414
[TBL] [Abstract][Full Text] [Related]
8. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
[TBL] [Abstract][Full Text] [Related]
9. [Primary and secondary prevention for erysipelas].
Becq-Giraudon B
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):368-75. PubMed ID: 11319367
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
Vignes S; Dupuy A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
[TBL] [Abstract][Full Text] [Related]
11. [Consensus conference. Erysipelas and necrotizing fasciitis. Short text].
J Mal Vasc; 2000 Oct; 25(4):270-5. PubMed ID: 11060422
[No Abstract] [Full Text] [Related]
12. Erysipelas: recognition and management.
Bonnetblanc JM; Bédane C
Am J Clin Dermatol; 2003; 4(3):157-63. PubMed ID: 12627991
[TBL] [Abstract][Full Text] [Related]
13. [Which treatment for erysipelas? Antibiotic treatment: drugs and methods of administering].
Lucht F
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):345-7. PubMed ID: 11319362
[TBL] [Abstract][Full Text] [Related]
14. [What data is needed today to deal with erysipelas?].
Hansmann Y
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):419-28. PubMed ID: 11319374
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent erysipelas].
Dangoisse C; Ledoux M
Rev Med Brux; 1991 Sep; 12(7):253-6. PubMed ID: 1925175
[TBL] [Abstract][Full Text] [Related]
16. [Erysipelas. Retrospective study of 647 patients].
Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
[TBL] [Abstract][Full Text] [Related]
17. Dermo-hypodermal bacterial infections. Current concepts.
Bernard P
Eur J Med; 1992 May; 1(2):97-104. PubMed ID: 1342380
[No Abstract] [Full Text] [Related]
18. [Bacterial acute non necrosing cellulitis (erysipelas) in adult].
Dezoteux F; Staumont-Sallé D
Rev Med Interne; 2021 Mar; 42(3):186-192. PubMed ID: 33176944
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and therapy of erysipelas: A position paper of the Society Initiative Chronische Wunde (ICW) e. V.].
Kröger K; Schwarzkopf A; Eder S; Protz K; Münter C; Dissemond J
Dtsch Med Wochenschr; 2021 Jun; 146(12):822-830. PubMed ID: 34130325
[TBL] [Abstract][Full Text] [Related]
20. Recurrent erysipelas: 47 cases.
Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
